Evaluation of interleukin-17 serum levels in patients with chronic myeloproliferative diseases

Tumori. 2009 May-Jun;95(3):404-5. doi: 10.1177/030089160909500326.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood*
  • Chronic Disease
  • Female
  • Humans
  • Interleukin-17 / blood*
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / blood*
  • Predictive Value of Tests
  • Primary Myelofibrosis / blood

Substances

  • Biomarkers, Tumor
  • Interleukin-17